{"id":1350,"date":"2023-01-20T08:43:32","date_gmt":"2023-01-20T13:43:32","guid":{"rendered":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/?page_id=1350"},"modified":"2026-05-07T09:26:16","modified_gmt":"2026-05-07T13:26:16","slug":"overview","status":"publish","type":"page","link":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/","title":{"rendered":"Overview"},"content":{"rendered":"<!-- #2 NEWS START -->\r\n<style>\r\n#news-component { background-color: #090e24; margin-top: 0px !important; padding: 72px 0px 84px; }\r\n#news-component .news-cell { border-left: 1px solid rgba(255, 255, 255, 0.1); padding: 15px 0px 12px 24px; }\r\n#news-component h3 { margin-bottom: 34px !important; color: #fff !important; }\r\n#news-component h5 { margin-bottom: 12px !important; color: #fff !important; font-size: 16px; line-height: 24px !important; }\r\n#news-component p { margin-bottom: 12px !important; color: #fff !important; }\r\n#news-component a { color: #fff !important; outline: none; text-transform: uppercase; font-weight: bold; font-size: 14px; letter-spacing: 0.7px; }\r\n@media screen and (max-width: 1535px) {\r\n  #news-component .content-wrap { flex-direction: column-reverse; width: 696px; margin-left: auto; margin-right: auto; }\r\n}\r\n@media screen and (max-width: 767px) {\r\n  #news-component .content-wrap { width: 100%; }\r\n  #news-component .content-wrap .copy-wrap { padding: 66px; }\r\n  #news-component .news-cell img { display: none !important; }\r\n}\r\n@media screen and (max-width: 599px) {\r\n  #news-component .content-wrap .copy-wrap { padding: 33px; }\r\n  #news-component .news-cell img { display: none !important; }\r\n}\r\n<\/style>\r\n<!--\r\n<div class=\"row\" id=\"news-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-3 col-xl-3\">\r\n      <h3>Latest News & Updates<\/h3>\r\n    <\/div>\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-4 col-xl-4\">\r\n      <div class=\"news-cell\">\r\n        <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L26_website_brochurecover_510x660.png\" alt=\"brochure cover\" width=\"111\" height=\"144\" class=\"alignleft\" style=\"margin-right:24px;\" \/>\r\n        <h5>Full Agenda Now Available!<\/h5>\r\n        <a href=\".\/agenda\/\">View Now<\/a>\r\n<br style=\"clear: both;\"\/>\r\n      <\/div>\r\n    <\/div>\r\n\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-4 col-xl-4\">\r\n      <div class=\"news-cell\">\r\n        <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.canadianinstitute.com\/reference-site\/wp-content\/uploads\/sites\/2268\/2024\/12\/Reference-Placeholder-150x150.png\" alt=\"\" width=\"120\" height=\"120\" class=\"alignright\" style=\"margin-left:24px;\" \/>\r\n        <p><strong>Headline<\/strong><br \/>\r\n        Lorem ipsum dolor sit amet consectetur adipiscing elit nam ipsum elit lobortis et elit at blandit lobortis nisi nulla mauris odio.<\/p>\r\n        <a href=\"URL\" rel=\"noopener\" target=\"_blank\">Learn More<\/a> \r\n      <\/div>\r\n    <\/div>\r\n\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n-->\r\n<!-- #2 NEWS END -->\r\n\r\n\r\n<!-- #3 OPENING START -->\r\n<style>\r\n#intro-component { margin-top: 144px; margin-bottom: 168px; }\r\n#intro-component h2 { margin-bottom: 44px !important; }\r\n#intro-component h3 { margin-bottom: 35px !important; }\r\n#intro-component .copy-wrap { max-width: 848px; padding-right: 48px; }\r\n#intro-component .img-wrap img { border-radius: 2px; }\r\n#intro-component .vid-wrap { background-color: #f5f5f5; padding: 36px; border-radius: 2px; justify-content: center; }\r\n#intro-component .vid-wrap iframe { aspect-ratio: 16 \/ 9; width: 100% !important; }\r\n#intro-component .vid-wrap p { margin-top: 12px !important; margin-bottom: 5px !important; }\r\n#intro-component a.mainlink { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (max-width: 1279px) {\r\n  #intro-component { margin-top: 72px; margin-bottom: 96px; }\r\n  #intro-component .copy-wrap { max-width: initial; margin-bottom: 29px; }\r\n  #intro-component .img-wrap img { width: 100%; }\r\n}\r\n@media screen and (max-width: 1023px) {\r\n  #intro-component { margin-top: 72px; margin-bottom: 96px; }\r\n}\r\n@media screen and (max-width: 767px) {\r\n  #intro-component { margin-top: 72px; margin-bottom: 96px; }\r\n}\r\n@media screen and (max-width: 599px) {\r\n  #intro-component { margin-top: 48px; margin-bottom: 60px; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"intro-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-7 col-lg-7 col-xl-6\">\r\n      <div class=\"copy-wrap vertical-spacer-half\">\r\n        <h2>Europe&#8217;s Gold Standard Event for Pharma &#038; Biotech Patent Litigation<\/h2>\r\n        <p>C5&#8217;s Pharma &#038; Biotech Patent Litigation in Europe Forum brings together top litigators, government, industry associations and in-house counsel to explore the latest legal and regulatory developments impacting the life sciences industry.<\/p>\r\n        <p>Attend and gain practical insights on the UPC&#8217;s evolving jurisprudence, international and national European patent litigation strategies, and the EU&#8217;s regulatory changes.<\/p>\r\n        <p>Join us for two days of engagement with the European life sciences patent bar and shape the future of pharma and biotech litigation.<\/p>\r\n        <a href=\".\/agenda\/\" class=\"mainlink\">View Agenda<\/a>\r\n      <\/div>\r\n    <\/div>\r\n    <div class=\"col-xxxs-12 col-md-5 col-lg-5 col-xl-6\">\r\n      <a id=\"video\"><\/a>\r\n      <div class=\"vid-wrap\">\r\n        <iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/Wdmpz82O5io?si=qVG7gy6_GQfkh9bX\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\r\n        <p><strong>Welcome Message from the Co-Chairs<\/strong><\/p>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #3 OPENING END -->\r\n\r\n\r\n<!-- UPPER START -->\r\n<style>\r\n#upper-component { background-color: #F5F5F5; padding: 48px 0px 168px; }\r\n<\/style>\r\n<div class=\"row\" id=\"upper-component\">\r\n<div class=\"container\">\r\n\r\n<!-- #4 SPEAKERS START -->\r\n<style>\r\n#featured-speakers-component { padding: 96px 0px 0px; }\r\n#featured-speakers-component h2 { margin-bottom: 34px !important; }\r\n#featured-speakers-component .speaker-sections-wrap { margin-bottom: -79px; }\r\n#featured-speakers-component .speaker-section { margin-bottom: 79px; }\r\n#featured-speakers-component .speaker-wrap { display: flex; margin-left: -24px; margin-right: -24px; }\r\n#featured-speakers-component .speaker-wrap .speaker { width: 192px; margin-left: 24px; margin-right: 24px; text-align: center; }\r\n#featured-speakers-component .speaker-wrap .speaker img { border-radius: 36px; margin: 0 auto 19px; }\r\n#featured-speakers-component .speaker-wrap .speaker .name { font-weight: bold; margin-bottom: 3px; line-height: 24px; }\r\n#featured-speakers-component .speaker-wrap .speaker .details { font-size: 14px; line-height: 20px; }\r\n#featured-speakers-component a { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (max-width: 599px) {\r\n  #featured-speakers-component h6, #featured-speakers-component h2 { text-align: center; }\r\n  #featured-speakers-component .speaker-wrap { flex-direction: column; align-items: center; margin-left: 0; margin-right: 0; }\r\n  #featured-speakers-component .speaker-wrap .speaker { margin-bottom: 48px; margin-left: 0; margin-right: 0; }\r\n  #featured-speakers-component .speaker-wrap div.speaker:last-child { margin-bottom: 0; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"featured-speakers-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <div class=\"speaker-sections-wrap vertical-spacer\">\r\n        <div class=\"speaker-section\">\r\n\r\n          <div class=\"row\">\r\n            <div class=\"col-xxxs-12 col-md-6 col-lg-6 col-xl-6\">\r\n\r\n          <h2>Conference Co-Chairs<\/h2>\r\n          <div class=\"speaker-wrap\">\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/1562\/2021\/01\/penny-gilbert.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Penny Gilbert<\/p>\r\n              <p class=\"details\"><em>Partner<\/em><br><span style=\"font-weight:500;\">Powell Gilbert<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/1562\/2025\/03\/rose-hughes.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Dr. Rose Hughes, PhD, EPA<\/p>\r\n              <p class=\"details\"><em>European Patent Attorney<\/em><br><span style=\"font-weight:500;\">Evolve IP<\/span><\/p>\r\n            <\/div>\r\n\r\n          <\/div>\r\n\r\n            <\/div>\r\n            <div class=\"col-xxxs-12 col-md-4 col-lg-4 col-xl-4\">\r\n              <h2>Judiciary<\/h2>\r\n              <div class=\"speaker-wrap\">\r\n                <div class=\"speaker\">\r\n                  <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/03\/emmanuel-gouge.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n                  <p class=\"name\">Emmanuel Goug\u00e9<\/p>\r\n                  <p class=\"details\"><em>Judge (Legally Qualified)<\/em><br><span style=\"font-weight:500;\">UPC, Court of Appeal<\/span><\/p>\r\n                <\/div>\r\n                <div class=\"speaker\">\r\n                  <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/03\/florian-schweyer.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n                  <p class=\"name\">Dr. Florian Schweyer<\/p>\r\n                  <p class=\"details\"><em>Judge<\/em><br><span style=\"font-weight:500;\">7th Civil Chamber, Munich Regional Court<\/span><\/p>\r\n                <\/div>\r\n              <\/div>\r\n            <\/div>\r\n          <\/div>\r\n\r\n          <hr>\r\n\r\n          <h2>Government and Patent Offices<\/h2>\r\n          <div class=\"speaker-wrap\">\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2025\/03\/dr-martijn-de-lange.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Dr. Martijn de Lange<\/p>\r\n              <p class=\"details\"><em>Patent Examiner<\/em><br><span style=\"font-weight:500;\">Netherlands Patent Office<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2025\/04\/elodie-ferraty.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Elodie Ferraty<\/p>\r\n              <p class=\"details\"><em>Patent Examiner<\/em><br><span style=\"font-weight:500;\">INPI (French Patent Office)<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2021\/12\/rieke-kaup-2.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Rieke Kaup<\/p>\r\n              <p class=\"details\"><em>Case Handler<\/em><br><span style=\"font-weight:500;\">DG Comp, European Commission<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/stefanie-vukovic-1.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Dr. Stefanie Vukovic<\/p>\r\n              <p class=\"details\"><em>Patent Examiner<\/em><br><span style=\"font-weight:500;\">DPMA (German Patent Office)<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/fergal-brady.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Dr. Fergal Brady<\/p>\r\n              <p class=\"details\"><em>Patent Examiner<\/em><br><span style=\"font-weight:500;\">Intellectual Property Office of Ireland<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/03\/patrick-purcell.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Patrick Purcell<\/p>\r\n              <p class=\"details\"><em>Senior Patent Examiner<\/em><br><span style=\"font-weight:500;\">UK Intellectual Property Office<\/span><\/p>\r\n            <\/div>\r\n          <\/div>\r\n\r\n          <hr>\r\n\r\n          <h2>Featured Speakers<\/h2>\r\n          <div class=\"speaker-wrap\">\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/1562\/2024\/02\/Brigitte-Carion-Taravella.jpg\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Brigitte Carion-Taravella, PhD<\/p>\r\n              <p class=\"details\"><em>Principal Patent Counsel, Lead Biologics IP EU and EU Patent Policy<\/em><br><span style=\"font-weight:500;\">Sanofi (France)<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/1562\/2026\/02\/ruud-van-der-velden.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Ruud van der Velden<\/p>\r\n              <p class=\"details\"><em>Partner<\/em><br><span style=\"font-weight:500;\">Hogan Lovells LLP (the Netherlands)<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/1562\/2021\/12\/dr-kai-ruting.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Dr. Kai R\u00fcting<\/p>\r\n              <p class=\"details\"><em>Partner | UPC Representative<\/em><br><span style=\"font-weight:500;\">Vossius &#038; Partner (Germany)<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/claudia-trabuco.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Dr. Cl\u00e1udia Trabuco<\/p>\r\n              <p class=\"details\"><em>Global Head of Competition Law<\/em><br><span style=\"font-weight:500;\">Gilead Sciences (Portugal)<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/lucy-samuels.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Lucy Samuels<\/p>\r\n              <p class=\"details\"><em>Partner<\/em><br><span style=\"font-weight:500;\">Gill Jennings &#038; Every LLP (UK)<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2023\/02\/Sergio-Napolitano.jpg\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Sergio Napolitano<\/p>\r\n              <p class=\"details\"><em>General Counsel &#038; Director of External Relations<\/em><br><span style=\"font-weight:500;\">Medicines for Europe (Belgium)<\/span><\/p>\r\n            <\/div>\r\n          <\/div>\r\n\r\n        <\/div>\r\n      <\/div>\r\n      <a href=\".\/speakers\/\">View All Speakers<\/a>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #4 SPEAKERS END -->\r\n\r\n\r\n<!-- #6 TOPICS START -->\r\n<style>\r\n#topics-component { padding: 96px 0px 0px; }\r\n#topics-component .bullets-wrap { display: flex; flex-wrap: wrap; margin: 0 -24px -72px; }\r\n#topics-component .bullets-wrap .bullet { width: 312px; border-left: 1px solid rgba(0, 0, 0, 0.1); padding-left: 24px; margin: 0 24px 72px; }\r\n#topics-component .bullets-wrap .bullet img { margin-bottom: 0px; }\r\n#topics-component .bullets-wrap .bullet .cls-1 { background-color: #f5f5f5; margin-bottom: 0px; }\r\n#topics-component .bullets-wrap .bullet .cls-1 path { fill:#525252; stroke:#525252; stroke-width:0px; }\r\n#topics-component a { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (max-width: 1535px) {\r\n  #topics-component .bullets-wrap { margin: 0 -20px -60px; }\r\n  #topics-component .bullets-wrap .bullet { margin: 0 20px 60px; }\r\n}\r\n@media screen and (max-width: 1279px) {\r\n  #topics-component .bullets-wrap { margin: 0 -16px -48px; }\r\n  #topics-component .bullets-wrap .bullet { margin: 0 16px 48px; }\r\n}\r\n@media screen and (max-width: 1023px) {\r\n  #topics-component .bullets-wrap { margin: 0 -12px -36px; }\r\n  #topics-component .bullets-wrap .bullet { margin: 0 12px 36px; }\r\n}\r\n@media screen and (max-width: 767px) {\r\n  #topics-component { margin-bottom: 127px; }\r\n  #topics-component h2 { text-align: center; }\r\n  #topics-component .bullets-wrap { flex-direction: column; align-items: center; margin-left: 0; margin-right: 0; }\r\n  #topics-component .bullets-wrap .bullet { width: fit-content; padding-left: 0; margin-left: 0; margin-right: 0; border-left: none; text-align: center; }\r\n  #topics-component .bullets-wrap .bullet img { margin-left: auto; margin-right: auto; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"topics-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <h2>Gain Insights, Global Perspectives and Develop Winning Strategies<\/h2>\r\n      <div class=\"bullets-wrap vertical-spacer-quarter\">\r\n\r\n        <div class=\"bullet\">\r\n<!--GRAPH BARS UP-->\r\n<svg class=\"cls-1\" id=\"Layer_1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" version=\"1.1\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><defs><style>.st0{fill:#232323}<\/style><\/defs><path class=\"st0\" d=\"M55.325 51.386h-38.65c-.36 0-.655-.295-.655-.655s.295-.655.655-.655h38.65c.36 0 .655.295.655.655s-.295.655-.655.655\"\/><path class=\"st0\" d=\"M16.675 51.386a.657.657 0 0 1-.655-.655V22.068c0-.36.295-.655.655-.655s.655.295.655.655v28.67c0 .36-.295.655-.655.655Zm9.252-2.656h-6.012a.657.657 0 0 1-.655-.655v-4.651c0-.36.295-.655.655-.655h6.012c.36 0 .655.295.655.655v4.651c0 .36-.295.655-.655.655m-5.357-1.31h4.709v-3.341H20.57zm14.076 1.31h-6.012a.657.657 0 0 1-.655-.655v-9.008c0-.36.295-.655.655-.655h6.012c.36 0 .655.295.655.655v9.007c0 .36-.295.655-.655.655m-5.357-1.31h4.709v-7.704h-4.709zm14.077 1.311h-6.012a.657.657 0 0 1-.655-.655V34.704c0-.36.295-.655.655-.655h6.012c.36 0 .655.295.655.655v13.37c0 .36-.295.655-.655.655m-5.357-1.31h4.709v-12.06h-4.709zm14.076 1.311h-6.012a.657.657 0 0 1-.655-.655V30.348c0-.36.295-.655.655-.655h6.012c.36 0 .655.295.655.655v17.726c0 .36-.295.655-.655.655m-5.364-1.31h4.709V31.003h-4.709zM19.915 40.32a.654.654 0 0 1-.31-1.231l32.17-17.129a.65.65 0 0 1 .691.05.65.65 0 0 1 .259.641l-.598 3.341a.647.647 0 0 1-.756.526.65.65 0 0 1-.526-.756l.36-2.016-30.982 16.495a.7.7 0 0 1-.31.079\"\/><path class=\"st0\" d=\"M52.085 23.191a.7.7 0 0 1-.238-.043l-3.211-1.274a.653.653 0 0 1-.367-.85.654.654 0 0 1 .85-.367l3.211 1.274a.653.653 0 0 1-.238 1.26z\"\/><\/svg>\r\n          <p><strong>Analyze <\/strong>emerging litigation trends at the UPC, the UPC Court of Appeal, and national courts<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n<!--LOOKING GLASS CONNECTION ICON-->\r\n<svg class=\"cls-1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><path d=\"M57.78,22.64c.04-.75-.22-1.48-.73-2.03-.51-.55-1.2-.88-1.96-.91-.76-.04-1.48.22-2.04.73-.55.51-.88,1.2-.91,1.96-.03.59.13,1.17.45,1.66l-4.35,4.09c-1.72-5.77-7.06-9.99-13.38-9.99-7.7,0-13.97,6.26-13.97,13.97,0,.8.08,1.58.21,2.34l-2.58,2.66c-.4-.25-.86-.4-1.34-.42-.75-.04-1.48.22-2.03.73s-.88,1.2-.91,1.96c-.04.75.22,1.48.73,2.03.51.55,1.2.88,1.96.91h.13,0c1.5,0,2.76-1.18,2.82-2.69.03-.57-.12-1.13-.42-1.61l1.99-2.06c1.68,5.83,7.05,10.11,13.41,10.11,2.89,0,5.58-.88,7.81-2.4l9.38,9.38c.5.5,1.17.78,1.87.78h0c.71,0,1.37-.27,1.89-.78,1.03-1.04,1.03-2.71,0-3.74l-9.35-9.35s-.03-.01-.04-.03c1.52-2.23,2.41-4.93,2.41-7.83,0-.86-.09-1.7-.24-2.52l4.96-4.66c.39.23.82.37,1.29.39h.13c1.5,0,2.76-1.18,2.82-2.69ZM16.98,41.02c-.4-.01-.78-.19-1.05-.49-.27-.3-.41-.69-.4-1.09s.19-.78.49-1.05c.28-.26.64-.4,1.02-.4h.07c.4.01.78.19,1.05.49.27.3.41.69.4,1.09-.04.84-.76,1.49-1.58,1.45ZM22.2,32.12c0-6.98,5.67-12.66,12.66-12.66,5.96,0,10.96,4.15,12.29,9.7l-4.25,4c-.38-.22-.81-.36-1.27-.38-.75-.04-1.48.22-2.03.73-.06.06-.11.13-.17.19l-8.19-5c.1-.27.17-.55.18-.84.07-1.56-1.14-2.88-2.69-2.95-1.54-.06-2.88,1.14-2.95,2.7-.03.59.13,1.14.42,1.61l-3.94,4.06c-.03-.38-.06-.76-.06-1.15ZM40.48,34.46c.28-.26.64-.4,1.02-.4h.07c.84.04,1.48.75,1.45,1.58-.04.84-.76,1.49-1.58,1.45-.4-.01-.78-.19-1.05-.49-.27-.3-.42-.69-.4-1.09.01-.4.19-.78.49-1.05ZM27.08,27.66c.04-.81.71-1.45,1.52-1.45h.06c.84.04,1.48.75,1.45,1.58s-.76,1.48-1.58,1.45c-.84-.04-1.48-.75-1.45-1.58ZM54.88,50.24c.53.52.53,1.37-.01,1.91-.5.5-1.39.5-1.89,0l-9.25-9.25c.7-.57,1.34-1.21,1.91-1.91l9.25,9.25ZM47.51,32.12c0,6.98-5.68,12.66-12.66,12.66-6.03,0-11.08-4.25-12.35-9.9l4.61-4.75c.4.25.85.41,1.35.43h.13c.74,0,1.41-.29,1.92-.76l8.27,5.05c-.06.2-.09.41-.1.62-.04.75.22,1.48.73,2.03.51.55,1.2.88,1.96.91h.13c1.5.01,2.76-1.17,2.82-2.69.03-.62-.16-1.19-.47-1.68l3.57-3.36c.05.47.09.94.09,1.43ZM54.89,24.02c-.4-.01-.78-.19-1.05-.49-.27-.3-.41-.69-.4-1.09s.19-.78.49-1.05c.28-.26.64-.4,1.02-.4h.07c.4.01.78.19,1.05.49s.41.69.4,1.09c-.04.84-.75,1.49-1.58,1.45Z\"\/>\r\n          <p><strong>Engage <\/strong>with Judges from the UPC<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n<!--AI ICON-->\r\n<svg class=\"cls-1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><path d=\"M53.618 45.022c0-.713.576-1.296 1.296-1.296s1.296.576 1.296 1.296-.576 1.296-1.296 1.296-1.296-.576-1.296-1.296m-9.943 3.607c-.173.547-.151 1.058.065 1.613.72 1.858 1.404 3.701 2.225 5.897l.029.086c.029.086.086.223.086.266a.77.77 0 0 0 .662.85h.094a.77.77 0 0 0 .756-.67c.043-.41-.079-.742-.173-.986l-.029-.072a420 420 0 0 0-2.232-5.918c-.086-.23-.101-.403-.029-.619.266-.857.54-1.793.871-2.945l.036-.13c.014-.058.029-.122.05-.18h1.656c1.843.014 3.564.022 4.478-.022a2.82 2.82 0 0 0 2.7 2.023c1.548 0 2.808-1.26 2.808-2.808s-1.26-2.808-2.808-2.808a2.82 2.82 0 0 0-2.714 2.081c-.907.05-3.089.029-4.457.029-.626 0-1.13-.007-1.382 0h-.086c-1.123.007-1.426.238-1.721 1.296l-.036.122a99 99 0 0 1-.857 2.909m3.247-8.021c0-.979.792-1.786 1.786-1.786s1.786.792 1.786 1.786-.792 1.786-1.786 1.786-1.786-.792-1.786-1.786m-16.098 1.714c.475-.065.958-.05 1.469-.043.338 0 .684.007 1.037 0q.065 0 .108.043c.324.31.662.605.994.893l.778.691c.446.41.958.612 1.555.612h.108a37 37 0 0 1 2.534 0c.554.014.986-.166 1.339-.554.338-.367.684-.727 1.015-1.094.461-.482.929-.986 1.39-1.498h.756c.533.007 1.13.014 1.591-.014a3.31 3.31 0 0 0 3.211 2.549c1.822 0 3.298-1.483 3.298-3.298s-1.483-3.298-3.298-3.298a3.304 3.304 0 0 0-3.204 2.527c-.389.036-1.087.029-1.57.022-.324 0-.598-.007-.799 0-.317.007-.734.072-1.109.497-.439.497-.914.994-1.368 1.469-.346.367-.698.734-1.037 1.109-.043.05-.058.065-.187.058a53 53 0 0 0-2.621 0 .69.69 0 0 1-.569-.216c-.266-.245-.533-.475-.799-.713-.317-.281-.648-.569-.95-.857a1.6 1.6 0 0 0-1.217-.454c-.31.007-.619 0-.943 0-.547-.007-1.109-.022-1.699.058a.764.764 0 0 0-.655.85.764.764 0 0 0 .85.655m6.898-6.307c.979 0 1.786.792 1.786 1.786s-.792 1.786-1.786 1.786-1.764-.778-1.778-1.75v-.072a1.786 1.786 0 0 1 1.778-1.75m8.086-2.376c0-.713.576-1.296 1.296-1.296s1.296.576 1.296 1.296-.576 1.296-1.296 1.296c-.662 0-1.21-.504-1.282-1.152v-.144m-3.593-.554h-7.388c-.295 0-.554-.072-.886-.259-.792-.439-1.613-.857-2.398-1.26l-1.195-.619a2.55 2.55 0 0 0-1.267-.288h-3.938c-.274 0-.54.014-.799.029q-.172.002-.346.014a.756.756 0 1 0 .072 1.512c.122 0 .238-.007.36-.022.252-.014.49-.029.72-.029h3.938c.223 0 .389.036.554.122.403.209.799.418 1.202.626.778.403 1.584.821 2.362 1.246.562.31 1.094.446 1.634.446h1.98a3.3 3.3 0 0 0-2.333 2.419h-6.163a.756.756 0 1 0 0 1.512h6.163a3.31 3.31 0 0 0 3.211 2.542 3.3 3.3 0 0 0 3.298-3.298 3.31 3.31 0 0 0-2.426-3.182h5.119c.238 0 .497 0 .756-.014a2.82 2.82 0 0 0 2.642 1.85c1.548 0 2.808-1.26 2.808-2.808s-1.26-2.808-2.808-2.808a2.82 2.82 0 0 0-2.758 2.261c-.432.014-.871.007-1.318 0h-.792m-3.629-3.031a.885.885 0 1 1-.002-1.77.885.885 0 0 1 .002 1.77m0 1.519a2.412 2.412 0 0 0 0-4.824 2.41 2.41 0 0 0-2.268 1.606h-1.073c-.878-.007-1.786-.022-2.693.05a.76.76 0 0 0-.691.821.76.76 0 0 0 .756.698h.065c.835-.072 1.67-.058 2.549-.043h1.058a2.42 2.42 0 0 0 2.304 1.692m7.099-15.538c0 .979-.792 1.786-1.786 1.786s-1.786-.792-1.786-1.786.792-1.786 1.786-1.786 1.786.792 1.786 1.786m1.519 0a3.3 3.3 0 0 0-3.298-3.298 3.31 3.31 0 0 0-3.226 2.585h-1.843c-1.67 0-3.406.007-5.112-.007-1.519-.022-3.11.194-4.86.677-2.808.763-5.206 1.865-7.308 3.37-2.045 1.462-3.463 3.074-4.327 4.954-.59 1.289-.929 2.722-1.001 4.27-.058 1.246-.122 2.47-.202 3.931-.007.144-.101.331-.216.554-.583 1.152-1.166 2.29-1.75 3.442-.533 1.044-1.058 2.081-1.591 3.125-.382.756-.461 1.469-.23 2.102.238.648.77 1.138 1.577 1.469.252.101.504.216.756.317.468.194.95.403 1.44.59h.007l.014.086c.223 1.843.446 3.636.706 5.422.295 2.009 1.886 3.427 3.874 3.449 1.606.014 2.938-.036 4.176-.166.41-.043.835-.029 1.296-.022.202 0 .403.007.605.007.007.029.022.043.029.072.31.806.605 1.634.893 2.434l.324.886.18.482c.137.382.288.778.418 1.166l.086.23c.029.079.086.216.086.252a.76.76 0 0 0 .677.835h.079c.382 0 .72-.288.756-.684.043-.403-.086-.734-.18-.972a1 1 0 0 1-.058-.158c-.137-.41-.288-.814-.432-1.21-.058-.158-.122-.317-.18-.475q-.164-.442-.317-.886c-.288-.806-.59-1.642-.907-2.47-.108-.288-.403-1.037-1.296-1.037h-.014c-.23 0-.468 0-.706-.007-.482-.007-.979-.029-1.483.029-1.188.122-2.455.173-4.01.158-1.238-.007-2.196-.878-2.383-2.153a196 196 0 0 1-.698-5.386c-.029-.252-.122-1.001-.994-1.332-.461-.18-.936-.382-1.39-.569q-.38-.162-.77-.324c-.274-.115-.626-.31-.734-.59-.101-.274.029-.634.158-.886.533-1.044 1.058-2.081 1.591-3.132.583-1.152 1.166-2.29 1.75-3.449.158-.31.346-.684.374-1.152.086-1.469.144-2.7.202-3.953.058-1.346.346-2.585.857-3.694.749-1.627 2.002-3.053 3.823-4.349 1.958-1.397 4.19-2.419 6.826-3.139 1.634-.439 3.038-.641 4.442-.626 1.714.029 3.449.014 5.134.007h1.865a3.3 3.3 0 0 0 3.197 2.491 3.3 3.3 0 0 0 3.298-3.298m2.743 8.77a.885.885 0 1 1-1.77.002.885.885 0 0 1 1.77-.002m1.526 0a2.411 2.411 0 0 0-4.694-.77h-.144q-.91-.002-1.85.007c-.216 0-.317-.029-.454-.173a110 110 0 0 0-1.829-1.843 116 116 0 0 1-2.088-2.11c-.547-.569-1.116-.634-1.577-.634a396 396 0 0 1-4.997 0h-.533a.78.78 0 0 0-.799.158.76.76 0 0 0-.022 1.073c.346.353.77.302.907.281h.442c1.642 0 3.341.007 5.018 0 .252 0 .346.036.468.166.698.72 1.411 1.44 2.11 2.131.598.598 1.217 1.21 1.814 1.829.418.432.9.634 1.512.634h.072c.598-.014 1.21-.007 1.8-.007h.144a2.412 2.412 0 0 0 4.702-.756m6.854 4.334c0 .979-.792 1.786-1.786 1.786s-1.786-.792-1.786-1.786.792-1.786 1.786-1.786 1.786.792 1.786 1.786m1.519 0a3.3 3.3 0 0 0-3.298-3.298 3.305 3.305 0 0 0-3.211 2.549h-8.69c-.144 0-.158-.014-.216-.079-.59-.605-1.188-1.195-1.786-1.793-.734-.734-1.505-1.505-2.239-2.261-.425-.439-.922-.641-1.57-.634h-.677c-1.31.029-2.664.043-3.982 0-.922-.036-1.742.202-2.57.734-.706.461-1.44.914-2.146 1.354-.346.216-.698.432-1.044.648h-1.303c-1.015 0-2.066-.007-3.11.05a.764.764 0 0 0-.713.806.764.764 0 0 0 .806.713c1.001-.058 2.023-.05 3.017-.05h1.238c.252 0 .554-.029.85-.216.353-.223.713-.439 1.066-.662.72-.439 1.454-.907 2.174-1.375.562-.367 1.08-.518 1.685-.497 1.354.05 2.729.036 4.061.022h.677c.252-.007.346.036.468.158.749.763 1.512 1.534 2.254 2.275.59.59 1.188 1.188 1.771 1.786.36.367.77.533 1.289.533h.022c1.26-.007 5.256-.007 7.646 0h1.037a3.31 3.31 0 0 0 3.204 2.534 3.3 3.3 0 0 0 3.298-3.298\"\/><\/svg>\r\n          <p><strong>Demystify <\/strong>forum selection and parallel proceedings in the EU and the US<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n<!--GLOBE ICON-->\r\n<svg class=\"cls-1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><path d=\"M34.502 57.636c.41-2.052 1.829-3.463 2.448-3.989.302-.259.504-.605.59-1.001.252-1.188 1.642-2.174 2.225-2.549.288-.18.518-.446.67-.756a10.5 10.5 0 0 1 1.879-2.707q.15-.153.245-.317c.749-1.224.922-2.21.526-2.93-.389-.713-1.325-1.102-2.693-1.116a.94.94 0 0 1-.864-.598c-.396-1.03-1.397-1.555-2.736-1.426a.94.94 0 0 1-.576-.13c-2.563-1.534-4.586-2.052-5.998-1.548a2.69 2.69 0 0 0-1.634 1.649c-.151-.029-.482-.166-.835-.518-.302-.302-.806-.95-.72-1.879.029-.331.108-1.21-.526-1.469-.554-.23-1.087.245-1.483.691-.23-.158-.367-.338-.403-.526-.079-.374.202-.828.374-1.066a.684.684 0 0 0-.036-.857.67.67 0 0 0-.842-.144c-1.087.605-1.757.929-2.117 1.08-.526-.756-1.073-1.807-.734-2.549.41-.922 2.016-1.123 2.196-1.145a.9.9 0 0 0 .432-.173c.446-.317.85-.446 1.202-.374.526.115.936.684 1.195 1.13a.92.92 0 0 0 1.008.446.93.93 0 0 0 .72-.85c.043-.677.23-1.822 1.03-1.901a.96.96 0 0 0 .662-.374.92.92 0 0 0 .158-.72c-.086-.425.029-.626.238-.972.166-.274.374-.612.461-1.102.079-.425.526-1.066 1.202-1.714a.93.93 0 0 0 .173-1.116s-.173-.36.266-1.807c.245-.828-.014-1.267-.281-1.498-.857-.727-2.88 0-4.457.756-1.793-.173-2.498-.605-2.556-.929-.058-.302.389-.864 1.138-1.231.59-.288 1.094-.302 1.224-.151.49.547 1.015.828 1.57.806.72-.022 1.195-.533 1.375-.756a.85.85 0 0 0 .173-.382c.554-2.664 1.102-2.837 1.109-2.837.043 0 .194.108.353.338-.022.734.065 2.333 1.152 2.866.85.41 1.951.029 3.37-1.166 3.168-2.678 4.284-2.7 4.406-2.686h.007l.238-.54a21.5 21.5 0 0 1 6.797 2.902 1.13 1.13 0 0 0-.396 1.606l.029.043a.55.55 0 0 1-.144.756 2 2 0 0 1-.245.151c-.209.13-.482.288-.461.612.022.374.266.497 1.476 1.073l.216.101c.144.065.288.173.281.281-.022.158-.389.648-1.886.979a.64.64 0 0 0-.468.418.85.85 0 0 0 .108.778c0 .007.079.115.079.461 0 .151-.058.209-.151.259-.446.216-1.411-.029-1.685-.245-.202-.151-.454-.173-.662-.029-.533.353-.626 1.865-.418 2.678.216.842.698 1.008.972 1.03l.302.022c-.684.518-1.807 1.627-2.059 3.305-.252 1.735.482 3.607 2.189 5.587.274.317.691.454 1.102.36.799-.18 3.427-.648 3.809.878.245.986.31 2.074.36 3.031.072 1.346.137 2.412.662 2.938.396.396.576.763.742 1.08.115.245.23.468.418.648.101.094.223.187.353.288.547.41.677.576.569.77-.079.137-.151.266-.23.389-.36.598-.734 1.217-.972 2.549a8 8 0 0 1-.101.446c-3.946 4.082-9.482 6.631-15.588 6.631-.504 0-1.001-.022-1.498-.05M14.314 36c0-1.85.23-3.65.67-5.371.59.252 1.361.626 1.958 1.08.677.511 1.354 2.959 1.699 5.026a.87.87 0 0 0 .252.497c1.742 1.757 3.406 1.57 4.248 1.303a.44.44 0 0 1 .41.079c1.879 1.721 3.218 2.419 4.14 2.657-1.102 1.447-1.627 3.787-1.411 4.378a.5.5 0 0 0 .281.302c.18.216.662 1.13 1.339 2.714.029.079.05.173.065.295.079.684.619 1.382 1.606 2.074a.94.94 0 0 1 .396.828c-.079 1.188.554 3.01 1.174 4.32.151.317.338.698.562 1.08C21.787 55.267 14.292 46.49 14.292 36m24.451-23.515A25 25 0 0 0 36 12.327c-13.054 0-23.674 10.62-23.674 23.674S22.946 59.674 36 59.674 59.674 49.054 59.674 36c0-12.024-8.993-22.133-20.923-23.515\" \/><\/svg>\r\n          <p><strong>Navigate <\/strong>the evolving EU regulatory landscape and its impact on IP<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n<!--SCALES-->\r\n<svg class=\"cls-1\" id=\"Layer_1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" version=\"1.1\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><path class=\"st0\" d=\"M21.218 47.203c-4.716 0-8.273-3.312-8.273-7.711 0-.396.324-.72.72-.72h15.098c.396 0 .72.324.72.72 0 4.399-3.557 7.711-8.273 7.711Zm-6.79-6.991c.353 3.254 3.103 5.551 6.79 5.551s6.437-2.297 6.79-5.551H14.422Z\"\/><path class=\"st0\" d=\"M27.036 40.212a.72.72 0 0 1-.648-.403l-5.17-10.634-5.17 10.634a.72.72 0 0 1-.965.331.72.72 0 0 1-.331-.965l5.818-11.966c.238-.497 1.051-.497 1.296 0l5.818 11.966a.73.73 0 0 1-.331.965.7.7 0 0 1-.317.072M44.87 52.43a.72.72 0 0 1-.72-.72v-1.001a1.8 1.8 0 0 0-1.8-1.8H29.664a1.8 1.8 0 0 0-1.8 1.8v1.001c0 .396-.324.72-.72.72s-.72-.324-.72-.72v-1.001a3.244 3.244 0 0 1 3.24-3.24H42.35a3.244 3.244 0 0 1 3.24 3.24v1.001c0 .396-.324.72-.72.72\"\/><path class=\"st0\" d=\"M47.83 55.958a.72.72 0 0 1-.72-.72v-.756c0-1.13-.914-2.045-2.045-2.045H26.928c-1.13 0-2.045.914-2.045 2.045v.756c0 .396-.324.72-.72.72s-.72-.324-.72-.72v-.756a3.49 3.49 0 0 1 3.485-3.485h18.137a3.49 3.49 0 0 1 3.485 3.485v.756c0 .396-.324.72-.72.72M36 48.902a.72.72 0 0 1-.72-.72V20.578c0-.396.324-.72.72-.72s.72.324.72.72v27.605c0 .396-.324.72-.72.72\"\/><path class=\"st0\" d=\"M21.161 28.246c-1.08 0-2.254-.331-3.542-1.166a.713.713 0 0 1-.209-.994.714.714 0 0 1 .994-.209c3.139 2.038 5.285.36 7.762-1.584 2.743-2.146 5.846-4.586 10.296-.965.31.252.353.706.108 1.015a.727.727 0 0 1-1.015.108c-3.557-2.894-5.846-1.094-8.496.986-1.728 1.354-3.607 2.83-5.89 2.83Zm30.074 27.712h-30.47c-.396 0-.72-.324-.72-.72s.324-.72.72-.72h30.47c.396 0 .72.324.72.72s-.324.72-.72.72m-.453-8.755c-4.716 0-8.273-3.312-8.273-7.711 0-.396.324-.72.72-.72h15.098c.396 0 .72.324.72.72 0 4.399-3.557 7.711-8.273 7.711Zm-6.79-6.991c.353 3.254 3.103 5.551 6.79 5.551s6.437-2.297 6.79-5.551H43.985Z\"\/><path class=\"st0\" d=\"M56.599 40.212a.72.72 0 0 1-.648-.403l-5.17-10.634-5.17 10.634c-.173.36-.605.504-.965.331s-.504-.605-.331-.965l5.818-11.966c.238-.497 1.051-.497 1.296 0l5.818 11.966a.73.73 0 0 1-.331.965.7.7 0 0 1-.317.072\"\/><path class=\"st0\" d=\"M50.839 28.246c-2.282 0-4.162-1.476-5.89-2.83-2.657-2.081-4.946-3.874-8.496-.986a.721.721 0 1 1-.907-1.123c4.442-3.614 7.553-1.181 10.296.965 2.477 1.944 4.622 3.622 7.762 1.584a.72.72 0 0 1 .994.209.72.72 0 0 1-.209.994c-1.289.835-2.462 1.166-3.542 1.166ZM36 21.298c-1.447 0-2.628-1.181-2.628-2.628s1.181-2.628 2.628-2.628 2.628 1.181 2.628 2.628-1.181 2.628-2.628 2.628m0-3.816c-.655 0-1.188.533-1.188 1.188s.533 1.188 1.188 1.188 1.188-.533 1.188-1.188-.533-1.188-1.188-1.188\"\/><\/svg>\r\n          <p><strong>Adapt <\/strong>to EU competition law enforcement trends and cadence<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n<!--GLOBE ARROWS ICON-->\r\n<svg class=\"cls-1\" id=\"Layer_1\" data-name=\"Layer 1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" version=\"1.1\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><path d=\"M36.108 53.215c-9.497 0-17.215-7.726-17.215-17.215s7.726-17.215 17.215-17.215S53.323 26.51 53.323 36s-7.725 17.215-17.215 17.215m0-33.127c-8.77 0-15.912 7.135-15.912 15.912s7.135 15.912 15.912 15.912S52.02 44.777 52.02 36s-7.135-15.912-15.912-15.912\"\/><path d=\"M36.108 29.239a17.15 17.15 0 0 1-11.801-4.68.65.65 0 0 1-.029-.922.65.65 0 0 1 .922-.029c2.959 2.786 6.833 4.32 10.901 4.32s8.006-1.562 10.973-4.392a.65.65 0 0 1 .922.022.65.65 0 0 1-.022.922 17.14 17.14 0 0 1-11.88 4.752Zm-11.29 19.275a.65.65 0 0 1-.439-1.13c3.197-2.981 7.366-4.622 11.736-4.622s8.46 1.613 11.642 4.536c.266.245.281.655.036.922s-.655.281-.922.036c-2.945-2.7-6.761-4.19-10.757-4.19s-7.89 1.517-10.842 4.268a.66.66 0 0 1-.446.173Z\"\/><path d=\"M36.108 53.215c-5.234 0-9.338-7.56-9.338-17.215s4.104-17.215 9.338-17.215 9.338 7.56 9.338 17.215-4.104 17.215-9.338 17.215m0-33.127c-4.356 0-8.035 7.286-8.035 15.912s3.679 15.912 8.035 15.912S44.143 44.626 44.143 36s-3.679-15.912-8.035-15.912\"\/><path d=\"M52.675 36.655H19.548c-.36 0-.655-.295-.655-.655s.295-.655.655-.655h33.127c.36 0 .655.295.655.655s-.295.655-.655.655\"\/><path d=\"M36.108 53.215a.657.657 0 0 1-.655-.655V19.44c0-.36.295-.655.655-.655s.655.295.655.655v33.127c0 .36-.295.655-.655.655Z\"\/><path d=\"M36.108 57.895a21.8 21.8 0 0 1-15.113-6.055.65.65 0 0 1-.022-.922.65.65 0 0 1 .922-.022 20.48 20.48 0 0 0 14.213 5.688c11.347 0 20.585-9.238 20.585-20.585 0-.36.295-.655.655-.655s.655.295.655.655c0 12.074-9.821 21.895-21.895 21.895M14.875 36.655A.657.657 0 0 1 14.22 36c0-12.074 9.821-21.895 21.895-21.895 5.414 0 10.62 1.994 14.638 5.616a.66.66 0 0 1 .05.922.66.66 0 0 1-.922.05 20.52 20.52 0 0 0-13.766-5.278C24.768 15.415 15.53 24.646 15.53 36c0 .36-.295.655-.655.655\"\/><path d=\"M14.875 36.655a.65.65 0 0 1-.461-.194L12.153 34.2a.655.655 0 0 1 0-.922.657.657 0 0 1 .922 0l1.8 1.8 1.8-1.8c.252-.252.67-.252.922 0s.252.67 0 .922l-2.261 2.261a.65.65 0 0 1-.461.194m44.511 2.038a.65.65 0 0 1-.461-.194l-1.577-1.577-1.577 1.577a.657.657 0 0 1-.922 0 .655.655 0 0 1 0-.922l2.038-2.038a.657.657 0 0 1 .922 0l2.038 2.038a.656.656 0 0 1-.461 1.116\"\/><\/svg>\r\n          <p><strong>Redefine <\/strong>cross-border patent litigation strategy following the far-reaching <em>BSH v Electrolux<\/em> case<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n<!--MUNICIPAL GOVERNANCE ICON-->\r\n<svg class=\"cls-1\" data-name=\"Layer 1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><defs><clipPath id=\"a\"><path d=\"M13.458 12.94h44.087v44.087H13.458z\"\/><\/clipPath><\/defs><g style=\"clip-path:url(#a)\"><path d=\"M38.241 23.512c.608 1.328 1.045 3.038 1.236 4.954h-7.949c.19-1.915.628-3.626 1.236-4.954.749-1.642 1.725-2.661 2.739-2.661s1.99 1.02 2.739 2.661Zm.372-2.148c.328.455.631.979.899 1.567.685 1.495 1.172 3.41 1.371 5.532h4.133a9.74 9.74 0 0 0-2.627-4.749 9.8 9.8 0 0 0-3.776-2.353Zm-8.49 7.102c.199-2.125.685-4.038 1.371-5.532q.404-.883.899-1.567a9.8 9.8 0 0 0-3.776 2.353 9.75 9.75 0 0 0-2.627 4.749h4.133Zm25.309 11.578V52.63h-3.087v-7.776c0-1.679-1.374-3.053-3.053-3.053s-3.053 1.374-3.053 3.053v7.776h-3.087v-7.776c0-1.679-1.374-3.053-3.053-3.053s-3.053 1.374-3.053 3.053v7.776h-3.087v-7.776c0-1.679-1.374-3.053-3.053-3.053s-3.053 1.374-3.053 3.053v7.776h-3.088v-7.776c0-1.679-1.374-3.053-3.053-3.053s-3.053 1.374-3.053 3.053v7.776h-3.087V40.044zm0-1.4h-39.86v-1.892h39.859zm-29.601-8.778H45.17c.884 0 1.621.665 1.734 1.521h-22.81a1.756 1.756 0 0 1 1.734-1.521Zm-11.592 2.92h42.523c.193 0 .351.158.351.351v1.866a.35.35 0 0 1-.351.351h-42.52a.35.35 0 0 1-.351-.351v-1.866c0-.193.158-.351.351-.351Zm0 21.24h42.523c.193 0 .351.158.351.348v1.866a.35.35 0 0 1-.351.348h-42.52a.35.35 0 0 1-.351-.348v-1.866a.35.35 0 0 1 .351-.348Zm21.263-40.654c.527 0 .959.432.959.959h5.196l-1.092 1.944 1.092 1.944h-5.196v1.276q-.475-.042-.959-.04a10 10 0 0 0-.959.04v-5.164c0-.527.432-.959.959-.959Z\" \/><\/g><\/svg>\r\n          <p><strong>Respond <\/strong>to law-shaping decisions from the EPO and the EBA<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n<!--GEAR ICON-->\r\n<svg class=\"cls-1\" id=\"Layer_1\" data-name=\"Layer 1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" version=\"1.1\" viewBox=\"0 0 72 72\" width=\"72\" height=\"72\"><path d=\"M36 46.663c-5.882 0-10.663-4.781-10.663-10.663S30.118 25.337 36 25.337 46.663 30.118 46.663 36 41.882 46.663 36 46.663m0-20.016c-5.155 0-9.353 4.198-9.353 9.353s4.198 9.353 9.353 9.353 9.353-4.198 9.353-9.353-4.198-9.353-9.353-9.353\"\/><path d=\"M37.152 56.124h-2.304a3 3 0 0 1-2.995-2.995v-1.973a15.5 15.5 0 0 1-3.643-1.505l-1.397 1.397c-.569.569-1.318.878-2.117.878s-1.555-.31-2.117-.878l-1.627-1.627a3 3 0 0 1 0-4.234l1.397-1.397a15.5 15.5 0 0 1-1.505-3.643h-1.973a3 3 0 0 1-2.995-2.995v-2.297a3 3 0 0 1 2.995-2.995h1.973a15.5 15.5 0 0 1 1.505-3.643l-1.397-1.397c-.569-.569-.878-1.318-.878-2.117s.31-1.555.878-2.117l1.627-1.627c.569-.569 1.318-.878 2.117-.878s1.555.31 2.117.878l1.397 1.397a15.5 15.5 0 0 1 3.643-1.505v-1.973a3 3 0 0 1 2.995-2.995h2.304a3 3 0 0 1 2.995 2.995v1.973c1.274.346 2.498.857 3.643 1.505l1.397-1.397c.569-.569 1.318-.878 2.117-.878s1.555.31 2.117.878l1.627 1.627c.569.569.878 1.318.878 2.117s-.31 1.555-.878 2.117l-1.397 1.397a15.5 15.5 0 0 1 1.505 3.643h1.973a3 3 0 0 1 2.995 2.995v2.297a3 3 0 0 1-2.995 2.995h-1.973a15.5 15.5 0 0 1-1.505 3.643l1.397 1.397a3 3 0 0 1 0 4.234l-1.627 1.627c-.569.569-1.318.878-2.117.878s-1.555-.31-2.117-.878l-1.397-1.397a15.5 15.5 0 0 1-3.643 1.505v1.973a3 3 0 0 1-2.995 2.995m-8.705-7.855a14.4 14.4 0 0 0 4.212 1.742.654.654 0 0 1 .504.634v2.484c0 .929.756 1.685 1.685 1.685h2.304c.929 0 1.685-.756 1.685-1.685v-2.484a.65.65 0 0 1 .504-.634 14.4 14.4 0 0 0 4.205-1.735q.002.002.014-.007l.043-.022a.65.65 0 0 1 .792.166l1.714 1.714c.641.641 1.75.641 2.383 0l1.627-1.627a1.683 1.683 0 0 0 0-2.39l-1.714-1.714a.66.66 0 0 1-.166-.792l.029-.05a14.3 14.3 0 0 0 1.742-4.212.654.654 0 0 1 .634-.504h2.484c.929 0 1.685-.756 1.685-1.685v-2.297c0-.929-.756-1.685-1.685-1.685h-2.484a.65.65 0 0 1-.634-.504 14.1 14.1 0 0 0-1.742-4.205.655.655 0 0 1 .094-.806l1.757-1.757a1.683 1.683 0 0 0 0-2.39l-1.627-1.627c-.641-.641-1.75-.641-2.383 0l-1.757 1.757a.654.654 0 0 1-.806.094 14.4 14.4 0 0 0-4.205-1.742.654.654 0 0 1-.504-.634v-2.484c0-.929-.756-1.685-1.685-1.685h-2.304c-.929 0-1.685.756-1.685 1.685v2.484a.65.65 0 0 1-.504.634c-1.49.353-2.909.936-4.205 1.742a.654.654 0 0 1-.806-.094l-1.757-1.757c-.641-.641-1.75-.641-2.383 0l-1.627 1.627a1.683 1.683 0 0 0 0 2.39l1.757 1.757a.654.654 0 0 1 .094.806 14.4 14.4 0 0 0-1.742 4.205.654.654 0 0 1-.634.504h-2.484c-.929 0-1.685.756-1.685 1.685v2.297c0 .929.756 1.685 1.685 1.685h2.484a.65.65 0 0 1 .634.504c.353 1.49.943 2.909 1.742 4.212s.022.036.029.05a.65.65 0 0 1-.166.792l-1.714 1.714a1.683 1.683 0 0 0 0 2.39l1.627 1.627c.641.634 1.75.641 2.383 0l1.714-1.714a.66.66 0 0 1 .792-.166l.05.029Z\"\/><\/svg>\r\n          <p>Reconcile diverging standards for preliminary injunctions and the doctrine of equivalence<\/p>\r\n        <\/div>\r\n\r\n\r\n      <\/div>\r\n      <a href=\".\/agenda\/\"><strong style=\"text-decoration:underline;\">View Agenda<\/strong><\/a>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #6 TOPICS END -->\r\n\r\n\r\n\r\n\r\n\r\n<!-- UPPER END -->\r\n<\/div>\r\n<\/div>\r\n\r\n\r\n<!-- #8 ATTENDEES START -->\r\n<style>\r\n#attend-component { background-color: #242424; padding-top: 144px; padding-bottom: 168px; }\r\n#attend-component h2, #attend-component p, #attend-component li { color: #FFF !important; }\r\n#attend-component h2 { margin-bottom: 48px !important; }\r\n#attend-component p { margin-bottom: 12px; }\r\n#attend-component ul { padding-inline-start: 24px; }\r\n#attend-component li { font-size: 16px; line-height: 24px; margin-bottom: 8px; }\r\n#attend-component hr { margin: 72px 0px; border-top: 1px solid #525252; }\r\n#attend-component a { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #fff; }\r\n#attend-component .bullets-group-wrap { display: flex; justify-content: left; text-align: left; margin-left: -20px; margin-right: -20px; }\r\n#attend-component .bullets-group-wrap .bullets-group { width: 432px; margin-left: 20px; margin-right: 20px; }\r\n@media screen and (max-width: 1023px) {\r\n  #attend-component { background-size: 100%; padding-bottom: 188px; }\r\n  #attend-component .bullets-group-wrap { margin-left: 0; margin-right: 0; flex-direction: column; align-items: left; }\r\n  #attend-component .bullets-group-wrap .bullets-group { margin-left: 0; margin-right: 0; }\r\n}\r\n@media screen and (max-width: 599px) {\r\n  #attend-component { background-image: none; }\r\n}\r\n@media screen and (max-width: 427px) {\r\n  #attend-component .bullets-group-wrap .bullets-group { width: initial; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"attend-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <h2>Who Should Attend<\/h2>\r\n      <div class=\"bullets-group-wrap vertical-spacer-half\">\r\n        <div class=\"bullets-group\">\r\n          <p><strong>In-Housel Counsel and Executives from Pharmaceutical and&nbsp;Biotech Companies, including<\/strong>:<\/p>\r\n          <ul>\r\n              <li>Head of IP<\/li>\r\n              <li>Head of Patent Litigation<\/li>\r\n              <li>VP-Intellectual property<\/li>\r\n              <li>Scientific Director<\/li>\r\n              <li>Head of Legal \/ Legal Affairs<\/li>\r\n              <li>Principal Patent Examiner<\/li>\r\n              <li>Head of Global Strategy<\/li>\r\n              <li>Director Innovation, IP and Portfolio Management<\/li>\r\n              <li>R&#038;D Patent manager<\/li>\r\n              <li>Associate VP &#038; Director of Technology Licensing &#038; Commercialization<\/li>\r\n              <li>Patent Counsel<\/li>\r\n          <\/ul>\r\n        <\/div>\r\n        <div class=\"bullets-group\">\r\n          <p><strong>Law firm attorneys with<br>practices in<\/strong>:<\/p>\r\n          <ul>\r\n              <li>Intellectual Property and Patent Law<\/li>\r\n              <li>Life Sciences<\/li>\r\n              <li>European Patent Law<\/li>\r\n              <li>US Patent<\/li>\r\n          <\/ul>\r\n        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #8 ATTENDEES END -->\r\n\r\n\r\n<!-- #17 TESTIMONIALS START -->\r\n<style>\r\n#testimonials-component { padding-top: 144px; padding-bottom: 168px; }\r\n#testimonials-component .testimonials-wrap { display: flex; flex-wrap: wrap; margin: 0 -34px -75px; }\r\n#testimonials-component .testimonials-wrap .testimonial { width: 412px; margin: 0 34px 75px; }\r\n#testimonials-component .testimonials-wrap .testimonial blockquote { text-indent: 30px; padding: 0; border: none; margin: 0 0 25px; color: #242424; font-family: serif; font-style: normal; font-size: 18px; line-height:24px; }\r\n#testimonials-component .testimonials-wrap .testimonial figcaption { color: #242424; max-width: 360px; font-size: 14px; }\r\n@media screen and (max-width: 1023px) {\r\n  #testimonials-component .testimonials-wrap { margin-left: 0; margin-right: 0; justify-content: center; }\r\n  #testimonials-component .testimonials-wrap .testimonial { margin-left: 0; margin-right: 0; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"testimonials-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <div class=\"testimonials-wrap\">\r\n        <figure class=\"testimonial\">\r\n          <blockquote>\u201cThe combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.\u201d<\/blockquote>\r\n          <figcaption>&mdash;Dr. Andreas Geissler, LEUKOCARE AG<\/figcaption>\r\n        <\/figure>\r\n        <figure class=\"testimonial\">\r\n          <blockquote>\u201cGood networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.\u201d<\/blockquote>\r\n          <figcaption>&mdash;Anna Lopez Lozano, ESTEVE QU\u00cdMICA<\/figcaption>\r\n        <\/figure>\r\n        <figure class=\"testimonial\">\r\n          <blockquote>\u201cImportant subject matters to discuss presented by renowned specialists. An important conference to attend.\u201d<\/blockquote>\r\n          <figcaption>&mdash;Manuel Duraes Rocha, ABREU ADVOGADOS<\/figcaption>\r\n        <\/figure>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #17 TESTIMONIALS END -->\r\n","protected":false},"excerpt":{"rendered":"Europe&#8217;s Gold Standard Event for Pharma &#038; Biotech Patent Litigation C5&#8217;s Pharma &#038; Biotech Patent Litigation in Europe Forum brings together top litigators, government, industry associations and in-house counsel to explore the latest legal and regulatory developments impacting the life sciences industry. Attend and gain practical insights on the UPC&#8217;s evolving jurisprudence, international and national&hellip;","protected":false},"author":4924,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-event-overview.php","meta":{"footnotes":""},"class_list":["post-1350","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Overview | Pharma &amp; Biotech Patent Litigation in Europe<\/title>\n<meta name=\"description\" content=\"Join Europe\u2019s top life sciences patent professionals to explore legal advancements, UPC updates, and global strategies for pharma and biotech litigation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma &amp; Biotech Patent Litigation in Europe\" \/>\n<meta property=\"og:description\" content=\"Join Europe\u2019s top life sciences patent professionals to explore legal advancements, UPC updates, and global strategies for pharma and biotech litigation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma &amp; Biotech Patent Litigation in Europe\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-07T13:26:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L_linkedin_general_1200x1200.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/\",\"url\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/\",\"name\":\"Overview | Pharma &amp; Biotech Patent Litigation in Europe\",\"isPartOf\":{\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L26_website_brochurecover_510x660.png\",\"datePublished\":\"2023-01-20T13:43:32+00:00\",\"dateModified\":\"2026-05-07T13:26:16+00:00\",\"description\":\"Join Europe\u2019s top life sciences patent professionals to explore legal advancements, UPC updates, and global strategies for pharma and biotech litigation.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#primaryimage\",\"url\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L26_website_brochurecover_510x660.png\",\"contentUrl\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L26_website_brochurecover_510x660.png\",\"width\":510,\"height\":660},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Overview\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#website\",\"url\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/\",\"name\":\"Pharma & Biotech Patent Litigation in Europe\",\"description\":\"Template used to create new conference sites\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Overview | Pharma &amp; Biotech Patent Litigation in Europe","description":"Join Europe\u2019s top life sciences patent professionals to explore legal advancements, UPC updates, and global strategies for pharma and biotech litigation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/","og_locale":"en_US","og_type":"article","og_title":"Pharma &amp; Biotech Patent Litigation in Europe","og_description":"Join Europe\u2019s top life sciences patent professionals to explore legal advancements, UPC updates, and global strategies for pharma and biotech litigation.","og_url":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/","og_site_name":"Pharma &amp; Biotech Patent Litigation in Europe","article_modified_time":"2026-05-07T13:26:16+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L_linkedin_general_1200x1200.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/","url":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/","name":"Overview | Pharma &amp; Biotech Patent Litigation in Europe","isPartOf":{"@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#primaryimage"},"image":{"@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L26_website_brochurecover_510x660.png","datePublished":"2023-01-20T13:43:32+00:00","dateModified":"2026-05-07T13:26:16+00:00","description":"Join Europe\u2019s top life sciences patent professionals to explore legal advancements, UPC updates, and global strategies for pharma and biotech litigation.","breadcrumb":{"@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#primaryimage","url":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L26_website_brochurecover_510x660.png","contentUrl":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-content\/uploads\/sites\/1562\/2026\/02\/630L26_website_brochurecover_510x660.png","width":510,"height":660},{"@type":"BreadcrumbList","@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/"},{"@type":"ListItem","position":2,"name":"Overview"}]},{"@type":"WebSite","@id":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/#website","url":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/","name":"Pharma & Biotech Patent Litigation in Europe","description":"Template used to create new conference sites","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/pages\/1350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/users\/4924"}],"replies":[{"embeddable":true,"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/comments?post=1350"}],"version-history":[{"count":16,"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/pages\/1350\/revisions"}],"predecessor-version":[{"id":2808,"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/pages\/1350\/revisions\/2808"}],"wp:attachment":[{"href":"https:\/\/www.c5-online.com\/pharma-biotech-patent-litigation\/wp-json\/wp\/v2\/media?parent=1350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}